Surfactant Protein D Dampens Lung Injury by Suppressing NLRP3 Inflammasome Activation and NF-κB Signaling in Acute Pancreatitis.
Animals
Bronchoalveolar Lavage Fluid
Chemokines
/ metabolism
Cytokines
/ metabolism
Female
Humans
Immunity, Innate
Inflammasomes
/ metabolism
Inflammation
Lung Injury
/ metabolism
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
NF-kappa B
/ metabolism
NLR Family, Pyrin Domain-Containing 3 Protein
/ metabolism
Pancreatitis
/ metabolism
Pulmonary Surfactant-Associated Protein D
/ metabolism
Signal Transduction
Journal
Shock (Augusta, Ga.)
ISSN: 1540-0514
Titre abrégé: Shock
Pays: United States
ID NLM: 9421564
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
pubmed:
21
8
2018
medline:
9
6
2020
entrez:
21
8
2018
Statut:
ppublish
Résumé
Severe acute pancreatitis (SAP) often causes acute lung injury (ALI) by systemic inflammatory response. Surfactant protein D (SP-D) plays critical roles in host defense and inflammation regulation. NLRP3 inflammasomes and NF-κB signaling are key regulators in innate immunity and inflammation. We hypothesized that SP-D attenuates ALI by suppressing NLRP3 inflammasome and NF-κB activation. Wild-type C57BL/6 (WT), SP-D knockout (KO), and humanized transgenic SP-D (hTG) mice were used in this study. SAP was induced by administration of one-dose lipopolysaccharide (10 mg/kg) and 6 hourly intraperitoneal injections of cerulein (Cn) (100 μg/kg). Animals were killed 6 and 24 h after first Cn treatment. Histopathologic changes in pancreas and lung were assessed by light and electron microscopes. Serum amylase, IL-1β, IL-6, and MCP-1 levels were determined by kit/ELISA. NLRP3 inflammasome, NF-κB, and MPO activations were analyzed by western blotting and immunofluorescence. KO mice showed more severe pancreatic and lung injury than WT mice in SAP. hTG mice exhibited similar degree in lung injury as WT mice. Mitochondrial and rough endoplasmic reticulum damages, autophagosome formation were observed in the alveolar type II and acinar cells of SAP mice. SAP KO mice had increased bronchoalveolar lavage fluid inflammatory cells, higher levels of serum IL-1β, IL-6, and MCP-1 than SAP WT and hTG mice. Levels of NLRP3 inflammasome (NLRP3, ASC, and Caspase-1) and NF-κB activation in SAP KO mice were higher than SAP WT and hTG mice. SP-D exerts protective effects against ALI via suppressing NLRP3 inflammasome and NF-κB activation in experimental SAP.
Identifiants
pubmed: 30124598
doi: 10.1097/SHK.0000000000001244
pmc: PMC6393216
mid: NIHMS1502273
doi:
Substances chimiques
Chemokines
0
Cytokines
0
Inflammasomes
0
NF-kappa B
0
NLR Family, Pyrin Domain-Containing 3 Protein
0
Nlrp3 protein, mouse
0
Pulmonary Surfactant-Associated Protein D
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
557-568Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL136706
Pays : United States
Références
J Immunol. 2001 Jun 15;166(12):7514-9
pubmed: 11390505
Nat Rev Immunol. 2005 Jan;5(1):58-68
pubmed: 15630429
Am J Respir Cell Mol Biol. 2011 May;44(5):725-38
pubmed: 21531958
Gastroenterology. 2011 Jul;141(1):358-69
pubmed: 21439959
Gastroenterology. 2017 Nov;153(5):1212-1226
pubmed: 28918190
Am J Physiol Lung Cell Mol Physiol. 2012 Oct 1;303(7):L608-16
pubmed: 22886503
Curr Opin Crit Care. 2002 Apr;8(2):158-63
pubmed: 12386518
Gastroenterology. 2004 Jul;127(1):275-86
pubmed: 15236192
J Biol Chem. 2010 Apr 16;285(16):11998-2010
pubmed: 20048345
Front Med (Lausanne). 2018 Feb 08;5:18
pubmed: 29473039
Surg Infect (Larchmt). 2007 Feb;8(1):107-20
pubmed: 17381402
Shock. 2005 Dec;24 Suppl 1:45-51
pubmed: 16374372
Front Immunol. 2017 Oct 31;8:1337
pubmed: 29163464
Gastroenterology. 2014 Jun;146(7):1763-74
pubmed: 24657625
Mol Immunol. 2006 Mar;43(9):1293-315
pubmed: 16213021
Int J Clin Exp Pathol. 2017 Sep 01;10(9):9934-9944
pubmed: 31966883
Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):10178-10183
pubmed: 28878025
Hepatobiliary Pancreat Dis Int. 2010 Apr;9(2):201-7
pubmed: 20382594
J Clin Invest. 2012 Aug;122(8):2731-40
pubmed: 22850883
PLoS One. 2013;8(2):e56407
pubmed: 23437127
J Pathol. 2013 Jan;229(2):145-56
pubmed: 23097158
Compr Physiol. 2011 Jul;1(3):1365-81
pubmed: 23733646
Front Immunol. 2017 Nov 09;8:1518
pubmed: 29163554
Phytother Res. 2016 Apr;30(4):663-70
pubmed: 26833708
J Immunol. 2014 Jun 15;192(12):5974-83
pubmed: 24795455
Neuromolecular Med. 2010 Jun;12(2):149-63
pubmed: 19830599
Biomed Pharmacother. 2016 Dec;84:130-138
pubmed: 27643555
Biochem Pharmacol. 2012 Aug 1;84(3):331-40
pubmed: 22564908
Curr Opin Immunol. 2018 Feb;50:32-38
pubmed: 29128729
Am J Respir Cell Mol Biol. 2003 Oct;29(4):427-31
pubmed: 14500253
J Interferon Cytokine Res. 2009 Jun;29(6):313-26
pubmed: 19441883
Shock. 2015 Jan;43(1):31-8
pubmed: 25255378
Sci Rep. 2015 Dec 04;5:17798
pubmed: 26634656
Br J Surg. 2002 Mar;89(3):298-302
pubmed: 11872053
J Immunol. 2009 Jul 15;183(2):787-91
pubmed: 19570822
Yonsei Med J. 2016 Jan;57(1):5-14
pubmed: 26632377
Ann Surg. 1999 Feb;229(2):230-6
pubmed: 10024105
J Immunol. 2000 Jun 1;164(11):5866-70
pubmed: 10820266